Kaufman B, Mackey JR, Clemens MR. et al.
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive
metastatic breast cancer: results from the randomized phase III TAnDEM study.
J Clin Oncol 2009;
Download Bibliographical Data